Acute Bronchiolitis
ICD-10 J21 · ICD-11 CA41.Z

Treatment of Acute Bronchiolitis in Hospitalized Infants and Children

Acute bronchiolitis requiring hospital admission presents specific management challenges. In this inpatient population, the choice of inhalation therapy can directly influence the symptom trajectory and duration of the hospital stay.

Clinical Scenario

Infants and children hospitalized for bronchiolitis represent a distinct subset where evidence supports a targeted inhaled treatment approach — one that differs from outpatient management and warrants a structured, protocol-guided decision.

Treatment Approach

Current evidence supports the use of a specific nebulized inhalation therapy in this setting. The full agent selection, administration details, and combination considerations are defined in the complete regimen.

Goal: symptom improvement after 24 hours of treatment
Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1542/peds.2014-2742

  1. Clinicians may administer nebulized hypertonic saline to infants and children hospitalized for bronchiolitis (Evidence Quality: B; Recommendation Strength: Weak Recommendation [based on randomized controlled trials with inconsistent findings]).
  2. The preponderance of the evidence suggests that 3% saline is safe and effective at improving symptoms of mild to moderate bronchiolitis after 24 hours of use and reducing hospital LOS in settings in which the duration of stay typically exceeds 3 days.
View source ↗